Welcome to the Journal of Membrane Biology, a premier publication dedicated to advancing our understanding of the complex roles membranes play in biological systems. Published by Springer, this journal features research articles, reviews, and communications on a broad range of topics related to membrane biology, including biomolecular interactions, transport mechanisms, and physiological responses. With an ISSN of 0022-2631 and E-ISSN 1432-1424, the journal has been a cornerstone in the field since its inception in 1969 and continues to thrive as it looks towards 2024. Ranked in the second quartile (Q2) for Biophysics and Physiology, and third quartile (Q3) in Cell Biology, it showcases impactful research that embodies the spirit of scientific inquiry and innovation. Although currently not an Open Access journal, it remains easily accessible to researchers, professionals, and students eager to delve into the dynamic world of membrane studies. As the understanding of membrane dynamics expands, so does its relevance in areas such as drug development and cellular engineering, making the Journal of Membrane Biology an essential resource for those at the forefront of these critical scientific advancements.

OCL-Oilseeds and Fats Crops and Lipids is a renowned open-access journal published by EDP Sciences S A, specializing in the fields of agronomy, food science, and biochemistry. Since its inception in 2000, this journal has vigorously contributed to the advancement of research surrounding oilseeds and fats, addressing critical issues related to crop production, lipid analysis, and sustainable practices in food science. With an impressive impact factor reflected in its 2023 rankings—Q2 in Agronomy and Crop Science, Q3 in Biochemistry, and Q2 in Food Science—OCL stands out for its rigorous peer-review process and commitment to disseminating high-quality research. Its Scopus rankings further establish its reputation within the scientific community, occupying the 73rd and 64th percentiles in Agronomy and Food Science, respectively. This makes it an essential platform for researchers, professionals, and students focused on enhancing the understanding and application of lipid science and oilseed cultivation. Located in France, OCL encourages a global dialogue on innovations and discoveries that can drive the future of agricultural production and food technology.

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

Lipids in Health and Disease, published by BMC, stands as a leading open-access journal dedicated to advancing the understanding of lipid metabolism and its implications for health and disease. Since its inception in 2002, this journal has fostered accessibility to cutting-edge research, ensuring that knowledge in this vital field is disseminated widely to researchers, clinicians, and students worldwide. With a commendable Q1 ranking in multiple categories including Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, it appeals to a diverse readership, positioning itself at the forefront of research in biochemistry and medicine. It boasts an impressive Scopus rank, where it excels in areas such as Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, making it an essential resource for those looking to deepen their understanding of lipid biology and its clinical applications. Researchers can share and access findings that have significant implications for public health and disease prevention, emphasizing the journal's commitment to fostering innovation and collaboration in the scientific community.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, published by Elsevier, is a leading academic journal that focuses on advancing the field of lipid biology. With an ISSN of 1388-1981 and an E-ISSN of 1879-2618, this journal has established itself as an essential resource for researchers, professionals, and students interested in cell and molecular biology, particularly regarding lipid interactions and functions. The journal boasts an impressive impact factor, standing in the top quartiles of its categories—Q1 in Molecular Biology and Q2 in Cell Biology. As part of the vibrant academic landscape of the Netherlands, it supports both traditional and open access publication models, ensuring that vital research is accessible to a global audience. The converged years from 1998 to 2025 mark its sustained commitment to quality and relevance in the fast-evolving field of lipid research. With a strong ranking in Scopus and a percentile in the 80th range in both Molecular Biology and Cell Biology, this journal continues to be a pivotal platform for scholarly communication and innovation in lipid-related research.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, published by WILEY, is a reputable academic journal dedicated to advancing the field of lipid science and technology. With an ISSN of 1438-7697 and E-ISSN 1438-9312, this journal serves as a critical resource for researchers, professionals, and students interested in the bioengineering, industrial applications, and nutritional science of lipids. Covering a broad spectrum from biochemistry to food science, it holds distinguished rankings across multiple categories, including Q2 in Chemistry and Food Science, and Q3 in Biotechnology, showcasing its significance in the interdisciplinary study of lipids. The journal welcomes Open Access options, fostering the dissemination of knowledge and innovation in lipid research. With converged years extending from 2000 to 2024, this journal remains at the forefront of lipid-related research, encouraging scholarly contributions that push the boundaries of science and technology.

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.